BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24898660)

  • 1. Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in AβPP(L/S) transgenic mice.
    Nguyen TV; Shen L; Vander Griend L; Quach LN; Belichenko NP; Saw N; Yang T; Shamloo M; Wyss-Coray T; Massa SM; Longo FM
    J Alzheimers Dis; 2014; 42(2):459-83. PubMed ID: 24898660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A small molecule p75NTR ligand, LM11A-31, reverses cholinergic neurite dystrophy in Alzheimer's disease mouse models with mid- to late-stage disease progression.
    Simmons DA; Knowles JK; Belichenko NP; Banerjee G; Finkle C; Massa SM; Longo FM
    PLoS One; 2014; 9(8):e102136. PubMed ID: 25153701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer's mouse model.
    Knowles JK; Simmons DA; Nguyen TV; Vander Griend L; Xie Y; Zhang H; Yang T; Pollak J; Chang T; Arancio O; Buckwalter MS; Wyss-Coray T; Massa SM; Longo FM
    Neurobiol Aging; 2013 Aug; 34(8):2052-63. PubMed ID: 23545424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule modulation of the p75 neurotrophin receptor inhibits multiple amyloid beta-induced tau pathologies.
    Yang T; Tran KC; Zeng AY; Massa SM; Longo FM
    Sci Rep; 2020 Nov; 10(1):20322. PubMed ID: 33230162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the p75 neurotrophin receptor using LM11A-31 prevents diabetes-induced retinal vascular permeability in mice via inhibition of inflammation and the RhoA kinase pathway.
    Elshaer SL; Alwhaibi A; Mohamed R; Lemtalsi T; Coucha M; Longo FM; El-Remessy AB
    Diabetologia; 2019 Aug; 62(8):1488-1500. PubMed ID: 31073629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A small molecule p75NTR ligand normalizes signalling and reduces Huntington's disease phenotypes in R6/2 and BACHD mice.
    Simmons DA; Belichenko NP; Ford EC; Semaan S; Monbureau M; Aiyaswamy S; Holman CM; Condon C; Shamloo M; Massa SM; Longo FM
    Hum Mol Genet; 2016 Nov; 25(22):4920-4938. PubMed ID: 28171570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule modulation of the p75 neurotrophin receptor suppresses age- and genotype-associated neurodegeneration in HIV gp120 transgenic mice.
    Xie Y; Seawell J; Boesch E; Allen L; Suchy A; Longo FM; Meeker RB
    Exp Neurol; 2021 Jan; 335():113489. PubMed ID: 33007293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the p75 neurotrophin receptor attenuates neuroinflammation and stimulates hippocampal neurogenesis in experimental Streptococcus pneumoniae meningitis.
    Zhang D; Zhao S; Zhang Z; Xu D; Lian D; Wu J; He D; Sun K; Li L
    J Neuroinflammation; 2021 Nov; 18(1):253. PubMed ID: 34727939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute administration of the small-molecule p75(NTR) ligand does not prevent hippocampal neuron loss or development of spontaneous seizures after pilocarpine-induced status epilepticus.
    Grabenstatter HL; Carlsen J; Raol YH; Yang T; Hund D; Cruz Del Angel Y; White AM; Gonzalez MI; Longo FM; Russek SJ; Brooks-Kayal AR
    J Neurosci Res; 2014 Oct; 92(10):1307-18. PubMed ID: 24801281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-Stroke Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Attenuates Chronic Changes in Brain Metabolism, Increases Neurotransmitter Levels, and Improves Recovery.
    Nguyen TV; Crumpacker RH; Calderon KE; Garcia FG; Zbesko JC; Frye JB; Gonzalez S; Becktel DA; Yang T; Tavera-Garcia MA; Morrison HW; Schnellmann RG; Longo FM; Doyle KP
    J Pharmacol Exp Ther; 2022 Feb; 380(2):126-141. PubMed ID: 34893553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington's Disease: Preclinical Evidence with the p75
    Simmons DA; Mills BD; Butler Iii RR; Kuan J; McHugh TLM; Akers C; Zhou J; Syriani W; Grouban M; Zeineh M; Longo FM
    Neurotherapeutics; 2021 Apr; 18(2):1039-1063. PubMed ID: 33786806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75 NTR.
    Friesland A; Weng Z; Duenas M; Massa SM; Longo FM; Lu Q
    Neurotoxicology; 2014 Dec; 45():81-90. PubMed ID: 25277379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's disease.
    Yao XQ; Jiao SS; Saadipour K; Zeng F; Wang QH; Zhu C; Shen LL; Zeng GH; Liang CR; Wang J; Liu YH; Hou HY; Xu X; Su YP; Fan XT; Xiao HL; Lue LF; Zeng YQ; Giunta B; Zhong JH; Walker DG; Zhou HD; Tan J; Zhou XF; Wang YJ
    Mol Psychiatry; 2015 Nov; 20(11):1301-10. PubMed ID: 25917367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the p75 neurotrophin receptor suppresses age-related basal forebrain cholinergic neuron degeneration.
    Xie Y; Meeker RB; Massa SM; Longo FM
    Sci Rep; 2019 Mar; 9(1):5273. PubMed ID: 30918278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-molecule modulation of the p75 neurotrophin receptor inhibits a wide range of tau molecular pathologies and their sequelae in P301S tauopathy mice.
    Yang T; Liu H; Tran KC; Leng A; Massa SM; Longo FM
    Acta Neuropathol Commun; 2020 Sep; 8(1):156. PubMed ID: 32891185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SorLA deficiency dissects amyloid pathology from tau and cholinergic neurodegeneration in a mouse model of Alzheimer's disease.
    Capsoni S; Carlo AS; Vignone D; Amato G; Criscuolo C; Willnow TE; Cattaneo A
    J Alzheimers Dis; 2013; 33(2):357-71. PubMed ID: 22986780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of p75-dependent motor neuron death by a small non-peptidyl mimetic of the neurotrophin loop 1 domain.
    Pehar M; Cassina P; Vargas MR; Xie Y; Beckman JS; Massa SM; Longo FM; Barbeito L
    Eur J Neurosci; 2006 Sep; 24(6):1575-80. PubMed ID: 17004921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Improves Erectile Function in a Mouse Model of Cavernous Nerve Injury.
    Yin GN; Ock J; Limanjaya A; Minh NN; Hong SS; Yang T; Longo FM; Ryu JK; Suh JK
    J Sex Med; 2021 Jan; 18(1):17-28. PubMed ID: 33243690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
    Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
    J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.
    Wang QH; Wang YR; Zhang T; Jiao SS; Liu YH; Zeng F; Li J; Yao XQ; Zhou HD; Zhou XF; Wang YJ
    J Neurochem; 2016 Jul; 138(1):163-73. PubMed ID: 26991827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.